1Lankas G R,Wise L D,Cartwright M E,et al.Placental p-gly coprotein deficiency enhance ssusceptibiliy to chemically induced birth defects in mice [J].Reprod Toxicol,1998,12(4):457-63.
2Lampilis T.J.Krishan A,Planas L.and Tapiero H.Reversal of in trinsicre resistance to adriamycin in normal cell sbyverapamiil [J].Cancer Drug Deliv.1986,3(4):251-9.
3Juliano RL,Ling V.Asurface glycoprotein modulating drug permeability in Chinese hamasterovary cell mutants[J].Bioch in Biophys Acta,1976,455:152-154.
4Kartner N,Riordan,Ling V.Cell surface p-glycoprotein is associated with mu ltidrug resistance in mammalian cell lines[J].Science,1983,221:1285-1287.
5Zaman GJR,Versantvoort CHM,Smit JJM,etal.Analysis of the expression of MRP,the gene for a new putative transmembrane drug transporter in human Multidrug resistance lung cancer cell lines[J].Cance Res,1993,53:1747-1749.
6Yang WZ,Begleiter A,Johnston JB,et al.Role of glutathione and glutathione s-transferase in Chlorambucil resistance[J].Mol Phzrm,1992,41:625-6285.
7Block SM,Wolf R.The role of glutathione-dependent enzymes in drug resistance[J].Pharm.Ther,1991,51:139-143.
8Yu TH,Wolf JK,Scanlon M,er al.Enhanced c-erb B2/neu expression in ovarian cancer cells correlates with more severe malignant that can be suppressed by ELA [J].Cancer Res,1993,53:891-895.
9Gusterson BA Gelber GD,Goldhirsch A,et al.Prognostic importance of c-erbB2 expression in breast cancer[J].J Clin Oncol,1992,10:1049-1052.
10Pegram MD.Effect of erbB2 over expression on chemotherapeutic drug sensiti vity in human breast ovarian cancer cells[J].Am Assoc Cancer Res,1993,34:A152 -155.
